Osteoarthritis
Osteoarthritis (OA) is a complex musculoskeletal disorder with profound social and economic costs.
OA is one of the top five causes of disability in the US, affecting 27-million Americans, including about 14% of adults aged 25 and older, 80% of the population over 65, and costing the Nation 1-2.5% of its gross domestic product.

27
Million
Americans
affected
1%-2.5%
of US gross
domestic product
Top 5
OA is one of the
top 5 causes of disability
in the US.

Stem cell-enriched products have been reported to promote clinical benefits in OA via anti-inflammatory and regenerative activities.
StroMel™ - FDA-approved clinical trials in the US
However, there is no FDA-approved stem cell therapy available to patients in the US. Akan’s investigational product, StroMel™, is one of the few non-expanded native stem cell-based biological products currently in FDA-approved clinical trials in the US.